» Articles » PMID: 27527221

Modulation of Human Airway Barrier Functions During Burkholderia Thailandensis and Francisella Tularensis Infection Running Title: Airway Barrier Functions During Bacterial Infections

Overview
Journal Pathogens
Date 2016 Aug 17
PMID 27527221
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The bronchial epithelium provides protection against pathogens from the inhaled environment through the formation of a highly-regulated barrier. In order to understand the pulmonary diseases melioidosis and tularemia caused by Burkholderia thailandensis and Fransicella tularensis, respectively, the barrier function of the human bronchial epithelium were analysed. Polarised 16HBE14o- or differentiated primary human bronchial epithelial cells (BECs) were exposed to increasing multiplicities of infection (MOI) of B. thailandensis or F. tularensis Live Vaccine Strain and barrier responses monitored over 24-72 h. Challenge of polarized BECs with either bacterial species caused an MOI- and time-dependent increase in ionic permeability, disruption of tight junctions, and bacterial passage from the apical to the basolateral compartment. B. thailandensis was found to be more invasive than F. tularensis. Both bacterial species induced an MOI-dependent increase in TNF-α release. An increase in ionic permeability and TNF-α release was induced by B. thailandensis in differentiated BECs. Pretreatment of polarised BECs with the corticosteroid fluticasone propionate reduced bacterial-dependent increases in ionic permeability, bacterial passage, and TNF-α release. TNF blocking antibody Enbrel(®) reduced bacterial passage only. BEC barrier properties are disrupted during respiratory bacterial infections and targeting with corticosteroids or anti-TNF compounds may represent a therapeutic option.

Citing Articles

Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy.

Gao N, Rezaee F Pharmaceutics. 2022; 14(12).

PMID: 36559113 PMC: 9786141. DOI: 10.3390/pharmaceutics14122619.


Integrating an aerosolized drug delivery device with conventional static cultures and a dynamic airway barrier microphysiological system.

Karra N, Fernandes J, Swindle E, Morgan H Biomicrofluidics. 2022; 16(5):054102.

PMID: 36118260 PMC: 9473724. DOI: 10.1063/5.0100019.


Temporal Whole-Transcriptomic Analysis of Characterized and Primary Nasal Epithelia.

Legebeke J, Horton K, Jackson C, Coles J, Harris A, Wai H Front Cell Dev Biol. 2022; 10:907511.

PMID: 35784475 PMC: 9240208. DOI: 10.3389/fcell.2022.907511.


Erratum: Blume, C., et al. Modulation of Human Airway Barrier Functions during and Infection Running Title: Airway Barrier Functions during Bacterial Infections. 2016, , 53.

Blume C, David J, Bell R, Laver J, Read R, Clark G Pathogens. 2020; 9(12).

PMID: 33256268 PMC: 7761030. DOI: 10.3390/pathogens9120987.


Probiotic Mixture Golden Bifido Prevents Neonatal K1 Translocation via Enhancing Intestinal Defense.

Zeng Q, He X, Puthiyakunnon S, Xiao H, Gong Z, Boddu S Front Microbiol. 2017; 8:1798.

PMID: 28979247 PMC: 5611410. DOI: 10.3389/fmicb.2017.01798.

References
1.
Xiao C, Puddicombe S, Field S, Haywood J, Broughton-Head V, Puxeddu I . Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011; 128(3):549-56.e1-12. DOI: 10.1016/j.jaci.2011.05.038. View

2.
Soong G, Parker D, Magargee M, Prince A . The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol. 2008; 190(8):2814-21. PMC: 2293221. DOI: 10.1128/JB.01567-07. View

3.
SASLAW S, CARLISLE H . Studies with tularemia vaccines in volunteers. IV. Brucella aggiutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis. Am J Med Sci. 1961; 242:166-72. DOI: 10.1097/00000441-196108000-00004. View

4.
Miyauchi E, OCallaghan J, Butto L, Hurley G, Melgar S, Tanabe S . Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am J Physiol Gastrointest Liver Physiol. 2012; 303(9):G1029-41. DOI: 10.1152/ajpgi.00003.2012. View

5.
Van Zandt K, Greer M, Gelhaus H . Glanders: an overview of infection in humans. Orphanet J Rare Dis. 2013; 8:131. PMC: 3766238. DOI: 10.1186/1750-1172-8-131. View